Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesMethyldopa-induced autoimmune haemolytic anaemia revisited
New Zealand Medical Journal, 08/26/09
Thomas A et al. – Drug–induced haemolytic anaemia is a commonly encountered clinical situation. Methyldopa–induced haemolytic anaemia, once the most common cause of drug induced haemolysis, is now rarely seen due to decline in its use. The authors report a case of methyldopa induced immune haemolytic anaemia in a young woman where the diagnosis was initially missed. The major mechanisms of drug induced immune haemolysis and unique characteristics of methyldopa induced haemolysis are also outlined.
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
The management of paracetamol poisoning
Paediatrics and Child Health, 11/09/09
A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding
Clinical Therapeutics, 11/02/09
Use of Fertility Drugs and Risk of Uterine Cancer: Results From a Large Danish Population-based Cohort Study
American Journal of Epidemiology, 11/04/09
Sponsor
Article Search
Sponsor